Susan Nmn Ungar

Array ( [id] => 3928415 [patent_doc_number] => 05952472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Anti-fibroblast growth factor-8 monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 8/832236 [patent_app_country] => US [patent_app_date] => 1997-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5128 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952472.pdf [firstpage_image] =>[orig_patent_app_number] => 832236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784615 [patent_doc_number] => 05821328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Genetic markers for breast, ovarian, and prostatic cancer' [patent_app_type] => 1 [patent_app_number] => 8/825886 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8908 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821328.pdf [firstpage_image] =>[orig_patent_app_number] => 825886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1160366 [patent_doc_number] => 06759036 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-06 [patent_title] => 'Fibrocyte-base vaccine formulations' [patent_app_type] => B1 [patent_app_number] => 08/828415 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 39 [patent_no_of_words] => 8321 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759036.pdf [firstpage_image] =>[orig_patent_app_number] => 08828415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409311 [patent_doc_number] => 06172188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Fluorescent proteins' [patent_app_type] => 1 [patent_app_number] => 8/819612 [patent_app_country] => US [patent_app_date] => 1997-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172188.pdf [firstpage_image] =>[orig_patent_app_number] => 819612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476203 [patent_doc_number] => 20020151689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'METHOD OF KILLING TARGET CELLS IN HARVESTED CELL POPULATIONS WITH ONE OR MORE IMMUNO-TOXINS' [patent_app_type] => new [patent_app_number] => 09/125751 [patent_app_country] => US [patent_app_date] => 1998-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9830 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151689.pdf [firstpage_image] =>[orig_patent_app_number] => 09125751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3953663 [patent_doc_number] => 05935796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown' [patent_app_type] => 1 [patent_app_number] => 8/765061 [patent_app_country] => US [patent_app_date] => 1997-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 8611 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935796.pdf [firstpage_image] =>[orig_patent_app_number] => 765061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947407 [patent_doc_number] => 05955302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Polynucleotide sequence encoding human dosage compensation-associated protein' [patent_app_type] => 1 [patent_app_number] => 8/795444 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 17264 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955302.pdf [firstpage_image] =>[orig_patent_app_number] => 795444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859623 [patent_doc_number] => 05792744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Proteins from mammalian liver' [patent_app_type] => 1 [patent_app_number] => 8/765957 [patent_app_country] => US [patent_app_date] => 1997-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1780 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792744.pdf [firstpage_image] =>[orig_patent_app_number] => 765957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928394 [patent_doc_number] => 05952471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Antibody that binds to cluster w-4 polypeptide of human small cell lung carcinoma cells' [patent_app_type] => 1 [patent_app_number] => 8/776694 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5572 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952471.pdf [firstpage_image] =>[orig_patent_app_number] => 776694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403207 [patent_doc_number] => 06270978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Immunomethods for isolating and indentifying human influx peptide transporter' [patent_app_type] => 1 [patent_app_number] => 8/792485 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9295 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270978.pdf [firstpage_image] =>[orig_patent_app_number] => 792485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750937 [patent_doc_number] => 20030045458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'METHOD AND COMPOSITION FOR TREATING CANCER BY CONVERTING SOLUBLE RADIOACTIVE TOXIC AGENTS INTO INSOLUBLE RADIOACTIVE TOXIC PRECIPITATES VIA THE ACTION OF NON-MAMMALIAN ENZYMES BOUND TO THE NON- ENDOCYTOSING RECEPTORS OF TARGET CELLS' [patent_app_type] => new [patent_app_number] => 08/782590 [patent_app_country] => US [patent_app_date] => 1997-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 14732 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045458.pdf [firstpage_image] =>[orig_patent_app_number] => 08782590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043828 [patent_doc_number] => 05912143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Polynucleotides encoding a human mage protein homolog' [patent_app_type] => 1 [patent_app_number] => 8/773870 [patent_app_country] => US [patent_app_date] => 1996-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19820 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912143.pdf [firstpage_image] =>[orig_patent_app_number] => 773870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946634 [patent_doc_number] => 05955259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method for assessing modulation of potassium ion channel activity' [patent_app_type] => 1 [patent_app_number] => 8/769745 [patent_app_country] => US [patent_app_date] => 1996-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9456 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955259.pdf [firstpage_image] =>[orig_patent_app_number] => 769745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045019 [patent_doc_number] => 05908781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Monoclonal antibodies to ceftiofur' [patent_app_type] => 1 [patent_app_number] => 8/766250 [patent_app_country] => US [patent_app_date] => 1996-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5381 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908781.pdf [firstpage_image] =>[orig_patent_app_number] => 766250 [rel_patent_id] =>[rel_patent_doc_number] =>)